UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 90 filers reported holding UROGEN PHARMA LTD in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,053,272 | +33.7% | 75,180 | -1.2% | 0.07% | +48.9% |
| Q2 2023 | $787,500 | +16.4% | 76,087 | +3.9% | 0.04% | +18.4% |
| Q1 2023 | $676,414 | +4.6% | 73,205 | +0.4% | 0.04% | +2.7% |
| Q4 2022 | $646,898 | +4.5% | 72,931 | -2.0% | 0.04% | +2.8% |
| Q3 2022 | $619,000 | -31.6% | 74,431 | -32.6% | 0.04% | -18.2% |
| Q2 2022 | $905,000 | -3.8% | 110,457 | +2.3% | 0.04% | +18.9% |
| Q1 2022 | $941,000 | -2.4% | 107,990 | +6.5% | 0.04% | +8.8% |
| Q4 2021 | $964,000 | -61.6% | 101,359 | -32.1% | 0.03% | -63.4% |
| Q3 2021 | $2,511,000 | -32.0% | 149,260 | -38.2% | 0.09% | -29.0% |
| Q2 2021 | $3,690,000 | -34.0% | 241,637 | -15.7% | 0.13% | -28.0% |
| Q1 2021 | $5,587,000 | +203.8% | 286,805 | +181.0% | 0.18% | +180.0% |
| Q4 2020 | $1,839,000 | – | 102,053 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Horton Capital Management, LLC | 684,749 | $11,517,000 | 23.27% |
| GREAT POINT PARTNERS LLC | 750,000 | $12,615,000 | 2.94% |
| HealthInvest Partners AB | 75,000 | $1,262,000 | 1.89% |
| Wildcat Capital Management, LLC | 533,139 | $8,967,000 | 1.16% |
| Annandale Capital, LLC | 86,254 | $1,451,000 | 0.87% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,954,699 | $49,698,000 | 0.73% |
| ZEKE CAPITAL ADVISORS, LLC | 723,677 | $12,172,000 | 0.70% |
| Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 25,330 | $426,000 | 0.34% |
| RTW INVESTMENTS, LP | 857,464 | $14,423,000 | 0.22% |
| SHIKIAR ASSET MANAGEMENT INC | 33,350 | $561,000 | 0.16% |